Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
A new strategy to prevent the most aggressive tumours from generating resistance to chemotherapy
One of the most frequent problems when treating cancer is that the tumours develop resistance…
Newly discovered immune cell type may be key to improving pancreatic cancer immunotherapy
Immunotherapy is showing great promise for treating cancer. But so far, this approach has been…
Directing nanoparticles straight to tumours
Modern anticancer therapies aim to attack tumour cells while sparing healthy tissue. An interdisciplinary team…
TROG 2015 Annual Scientific Meeting Review by Katie Vullo
Radiation oncology experts from across Australia and around the world gathered in Newcastle, NSW last month to unveil new research…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.